Skip to main content

Table 1 Values of ED50, Emax and slope (S) of log dose–response curves of cromakalim in the presence and absence of antagonists, such as butylidenephthalide (Bdph), 4-aminopyridine (4-AP) and glibenclamide (GBC) in conscious normotensive rats

From: Butylidenephthalide antagonizes cromakalim-induced systolic pressure reduction in conscious normotensive rats

Response

Antagonists

ED50 (mg/kg)

Emax

S

n

Change in systolic pressure (mmHg)

Bdph (30 mg/kg, i.p.)

0.25 ± 0.01a

−45 ± 5

−0.86 ± 0.04a

8

Vehicle (1 ml/kg, i.p.)

0.11 ± 0.00

−43 ± 6

−2.16 ± 0.29

8

4-AP (0.4 mg/kg, i.p.)

0.18 ± 0.00a

−30 ± 4

−0.82 ± 0.08a

6

Vehicle (1 ml/kg, i.p.)

0.10 ± 0.00

−34 ± 3

−1.83 ± 0.06

6

GBC (10 mg/kg, i.v.)

0.52 ± 0.01a

−53 ± 6

−1.08 ± 0.20

6

Vehicle (1 ml/kg, i.v.)

0.23 ± 0.01

−47 ± 4

−0.72 ± 0.15

6

  1. All values are shown as mean ± SEM, and n is the number of rats
  2. aSignificantly different from vehicle (P < 0.01)